Why this matters — Four distinct ORTEX data streams have converged on VELO (Velo3D) within days. Short interest, cost to borrow, utilisation, and options sentiment are all moving simultaneously — a rare multi-signal alignment.
Short Interest has risen sharply. SI hit 21.7% of free float as of April 24 — up 11.5% week-on-week and 67% over the past month. That brings short shares to approximately 4.55 million. The move accelerated from a base of ~2.6 million shares short in mid-March.
Cost to Borrow has surged. CTB stood at 22.4% APR on April 24 — up 242% over the prior week from 6.6% on April 17. As recently as early April, CTB was stable around 8–9%. The near-tripling in borrow cost reflects lenders repricing risk as demand for short positions intensifies.
Utilisation is near its 52-week peak. At 91.2% on April 24 — against a 52-week high of 97.8% — the share lending pool is almost fully deployed. Very little incremental borrowing capacity remains. ORTEX factor scores rank VELO's utilisation in the 2nd percentile, meaning it sits among the most utilised names in the market.
Options Sentiment is running in the opposite direction. The put/call ratio crashed to 0.27 on April 24. That is well below the 20-day average of 0.44 and carries a z-score of -1.60. The shift from a PCR above 1.05 in late March to 0.27 now tracks almost exactly with the stock's 54% one-week price gain.
ORTEX ranks VELO's short score at the 2nd percentile — among the most heavily shorted stocks by composite measure, with an absolute short score of 73.5. The analyst consensus is Buy, with a mean price target of $21.50 against the April 24 close of $17.36 — implying roughly 24% upside. Both covering analysts are at Buy. Vanguard added 515,900 shares in the most recent reporting period. Alyeska Investment Group entered with a new position of 2.4 million shares (9.2% of shares outstanding) as of December 2025. Insider activity is low-significance, consisting mainly of director awards.
The PCR trajectory is notable. It ran above 0.80 from mid-March through late March — then collapsed below 0.30 from April 20 onward. That inflection point coincides with the stock's sharp price recovery. A similar pattern of sustained bearish options positioning flipping abruptly to call dominance has historically accompanied sharp price moves in small-cap names with constrained borrow pools.
See the live data behind this article on ORTEX.
Open VELO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
